drugset / Trial / NCT03402438
Renal Impairment Study
Non-randomizedSingle-groupOpen-labelOther
Summary
The study will investigate the pharmacokinetics of BAY1142524 in subjects with mild to severe renal impairment compared to age; weight, and gender-matched healthy subjects.
Timeline
- Start
- 2018-02-12
- Primary completion
- 2018-12-04
- Completion
- 2019-03-19
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Fulacimstat | Small molecule | 25 mg | Oral |
Indications
No indication recorded.